4.7 Review

O-GlcNAcylation, enemy or ally during cardiac hypertrophy development?

期刊

出版社

ELSEVIER
DOI: 10.1016/j.bbadis.2016.08.012

关键词

Cardiac hypertrophy; Protein O-GlcNAcylation; Cardiac disease; Diabetes; Glucose

资金

  1. Fund for Scientific Research in Industry and Agriculture (FRIA), Belgium
  2. Fonds de Recherche Clinique from Universite catholique de Louvain (UCL), Belgium
  3. Fonds National de la Recherche Scientifique et Medicale, Belgium [T.0105.14]
  4. Action de Recherche Concertee, UCL, Belgium
  5. AstraZeneca, Belgium

向作者/读者索取更多资源

O-linked attachment of the monosaccharide beta-N-acetyl-glucosamine (O-GlcNAcylation) is a post-translational modification occurring on serine and threonine residues, which is evolving as an important mechanism for the regulation of various cellular processes. The present review will, first, provide a general background on the molecular regulation of protein O-GlcNAcylation and will summarize the role of this post-translational modification in various acute cardiac pathologies including ischemia-reperfusion. Then, we will focus on research studies examining protein O-GlcNAcylation in the context of cardiac hypertrophy. A particular emphasis will be laid on the convergent but also divergent actions of O-GlcNAcylation according to the type of hypertrophy investigated, including physiological, pressure overload-induced and diabetes-linked cardiac hypertrophy. In an attempt to distinguish whether O-GlcNAcylation is detrimental or beneficial, this review will present the different O-GlcNAcylated targets involved in hypertrophy development. We will finally argue on potential interest to target O-GlcNAc processes to treat cardiac hypertrophy. This article is part of a Special Issue entitled: The role of post translational protein modifications on heart and vascular metabolism edited by Jason R.B. Dyck & Jan F.C. Glatz. (C) 2016 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据